AFN-1252

N/A

Report date: 2022/07/04 19:38:02
NMEQIDP

Base Information

Drug NameAFN-1252
Drug Alias NameDebio-1452AFN-12520000AFN-1252API-1252
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionEnoyl-acyl-carrier protein reductase inhibitors
TargetsEnoyl-acyl-carrier protein reductase
Therapy Area/IndicationsAcute bacterial skin and skin structure infectionsWound InfectionAbscess +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffinium Pharmaceuticals LtdDebiopharm International Sa
Active IndicationsN/A
Inactive IndicationsAcute bacterial skin and skin structure infectionsWound InfectionAbscess +[5] 

Other Information

ATC CodeN/A
Related LinksN/A